评估退伍军人对治疗难以控制的高血压的脏缩的偏好:一项单中心调查研究
Benjamin L Magod1, Peter A Glynn2, Wesley J Manz3
1Department of Medicine Northwestern University Chicago Illinois USA.
Health science reports
|March 11, 2025
概括
如果建议,许多患有严重高血压的退伍军人更喜欢脏剥皮 (RDN) 而不是更多的药物. 患者对安全的高血压治疗方法RDN的偏好是共享决策的关键.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 导管式脏缩 (RDN) 是一种安全有效的高血压治疗方法.
- 关于患者对 RDN 的偏好存在有限的数据,特别是在退伍军人中.
- 了解患者的偏好对于优化高血压管理和转诊实践至关重要.
研究的目的:
- 评估难以控制高血压的退伍军人中患者对RDN的偏好.
- 为了确定影响RDN偏好的因素在这个人群中.
- 在高血压管理中为共享决策提供信息.
主要方法:
- 对100名随机选择的退伍军人进行了一项调查,这些退伍军人患有不受控制的高血压 (3+药物,肌素<2.5毫克/分升).
- 该调查评估了对 RDN 的偏好,期望和药物坚持 (MARS-5).
- 人口和临床数据是通过图表审查收集的.
主要成果:
- 在51名受访者中,43.1%的人更喜欢RDN,而64.7%的人更喜欢RDN而不是额外的药物,如果血压仍然无法控制.
- 结血性心力衰竭史和较低的药物坚持得分与RDN偏好有关.
- 年龄,副作用和治疗满意度与RDN偏好没有相关性.
结论:
- 很大一部分患有严重高血压的退伍军人喜欢RDN,当血压不受控制或医生推时.
- 这些发现支持将患者的偏好纳入高血压的共享决策.
- RDN偏好数据可以指导高血压退伍军人的管理策略.
更多相关视频
11:08Novel Approach for Simultaneous Recording of Renal Sympathetic Nerve Activity and Blood Pressure with Intravenous Infusion in Conscious, Unrestrained Mice.
Published on: February 14, 2018
10.1K
06:30Quantifying Acute Changes in Renal Sympathetic Nerve Activity in Response to Central Nervous System Manipulations in Anesthetized Rats
Published on: September 11, 2018
7.7K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
360
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
360
01:22Heart Failure Drugs: Diuretics
318
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
318
01:25Antihypertensive Drugs: Direct Renin Inhibitors
468
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
468
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
122
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
122
01:22Heart Failure Drugs: β-Blockers
303
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
303
01:23Antihypertensive Drugs: Vasodilators
455
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
455